AstraZeneca announced that it has filed patent infringement actions in United States District Court, District of Delaware, against seven generic drug manufacturers, which have submitted Abbreviated New Drug Applications (ANDAs) for Crestorâ„¢.
Discuss Add this link to...Bury Add to:
| Bookmarks
Comments